Evidence map›Paper›PMID 40253461›Full record

ArticleScientific reports2025

Determinants of retinopathy and short-term neurological outcomes after cerebral malaria.

Florence Bodeau-Livinec, Agnès Aubouy, Inès Besnard, Karl Angendu, Josselin Brisset, Jade Royo, Elisée Kinkpe, Linda Ayedadjou, Audrey Mowendabeka, Thomas Lathière and 4 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Florence Bodeau-Livinec *Ecole des hautes études en santé (EHESP), Institut de recherche en santé, environnement et travail (IRSET), 93210, Saint-Denis, France.
Agnès Aubouy *UMR152 PHARMADEV, Research Institute for Development (IRD), Toulouse 3 University, Toulouse, France.
Inès BesnardEcole des hautes études en santé (EHESP), Institut de recherche en santé, environnement et travail (IRSET), 93210, Saint-Denis, France.
Karl AngenduInserm U1094, IRD U270, Univ. Limoges, CHU Limoges, EpiMaCT - Epidemiology of chronic diseases in tropical zone, Institute of Epidemiology and Tropical Neurology, OmegaHealth, Limoges, France.
Josselin BrissetInfectious Diseases and Tropical Medicine Department, University Hospital, 2 Avenue Martin Luther King, 87000, Limoges, France.
Jade RoyoUMR152 PHARMADEV, Research Institute for Development (IRD), Toulouse 3 University, Toulouse, France.
Elisée KinkpePaediatric Department, Reference Hospital Centre, Abomey Calavi, Benin.
Linda AyedadjouPaediatric Department, Mother and Child University and Hospital Center (CHU-MEL), Cotonou, Benin.
Audrey MowendabekaDepartment of Neonatal Intensive Care Unit, University Hospital, Limoges, France.
Thomas LathièreOphtalmology department, University Hospital, Limoges, France.
Farid BoumedièneInserm U1094, IRD U270, Univ. Limoges, CHU Limoges, EpiMaCT - Epidemiology of chronic diseases in tropical zone, Institute of Epidemiology and Tropical Neurology, OmegaHealth, Limoges, France.
Ida Dossou-DagbaPaediatric Department, Reference Hospital Centre, Abomey Calavi, Benin.
Jules AlaoPaediatric Department, Mother and Child University and Hospital Center (CHU-MEL), Cotonou, Benin.
Jean-François FaucherInserm U1094, IRD U270, Univ. Limoges, CHU Limoges, EpiMaCT - Epidemiology of chronic diseases in tropical zone, Institute of Epidemiology and Tropical Neurology, OmegaHealth, Limoges, France. jean-francois.faucher@unilim.fr.

Funding

Agence Nationale de la Recherche ANR- 17-CE17-0001
6 · The paper itself

Abstract

Neurological abnormalities are frequent after cerebral malaria (CM) resolves. The identification of survivors that should be prioritized during follow-up after CM is necessary for post-hospitalization care. We analysed social, clinical, and immune determinants of malarial retinopathy (MR) and short-term neurological outcomes after CM. Children aged 24 to 71 months with CM were prospectively followed-up until 28 days after admission at two hospitals in Benin. Direct ophthalmoscopy was performed shortly after admission. Plasma biomarkers were measured at admission. A neurocognitive deficit screener was administered at discharge and 21-28 days after admission. Of 70 children, 20 died before discharge (28.6%). Neurological deficits decreased from 100% on admission to 48.9% at discharge, and to 16.7% at 21-28 days after admission. MR was found in 58% of children. In multivariate analysis, factors associated with MR were a traditional consultation before admission and study site. In addition, neurological deficits were associated with MR (Odds Ratio 5.54 95% CI (1.30-23.54)). In univariate analysis, higher plasma levels of angiopoietin-2 were associated with neurological deficit at discharge and at days 21-28 post-admission. Therefore, MR and endothelium activation may be markers of neurological deficit, the former at hospital discharge and the latter at discharge and at D21-D28 post-admission.

Indexed as

Malaria, CerebralNervous System DiseasesRetinal DiseasesAngiopoietin-2BeninBiomarkersChildChild, PreschoolFemaleHumansInfantMaleProspective StudiesAngiopoietin-2BiomarkersCerebral malariaChildrenImmune markersNeurological deficitRetinopathyWest Africa

Identifiers

PMID40253461
PMCPMC12009428

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.